Alto Neuroscience, Inc. (ANRO)
↓ Download CSVKey ratios (FY2025)
-41.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$66.36M | -$68.61M | -$37.81M | — |
| Net Income | -$63.24M | -$61.43M | -$36.30M | — |
| EPS (Diluted) | $-2.19 | $-2.50 | $-9.73 | — |
| Total Assets | $184.69M | $177.54M | $86.63M | — |
| Total Liabilities | $33.55M | $26.08M | $16.82M | — |
| Shareholders' Equity | $151.14M | $151.46M | -$71.67M | -$38.41M |
| Cash & Equivalents | $176.48M | $168.23M | $82.55M | — |
| Operating Cash Flow | -$51.77M | -$47.42M | -$33.45M | — |
| Capital Expenditures | $24.0K | $2.08M | $470.0K | — |
| Shares Outstanding | 31.92M | 26.99M | 3.83M | — |